Brii Biosciences Announces Board Composition
Company Announcements

Brii Biosciences Announces Board Composition

Brii Biosciences Limited (HK:2137) has released an update.

Brii Biosciences Limited has announced its Board of Directors’ composition, highlighting the mix of executive and independent non-executive members. The Board consists of seven individuals, including Dr. Zhi HONG and Dr. Ankang LI as Executive Directors, who also serve on multiple committees. Four Board committees are established to oversee various aspects of the company’s governance.

For further insights into HK:2137 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskBrii Biosciences Reports Mixed Mid-Year Financials
TipRanks HongKong Auto-Generated NewsdeskBrii Biosciences Schedules Key Financial Review Meeting
TipRanks HongKong Auto-Generated NewsdeskBrii Biosciences Confirms Stability Amid Partner’s Insolvency
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App